Clinical Trial Update: CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a calcineurin inhibitor-free de novo immunosuppression protocol in liver transplant patients with renal impairment; study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Liver Disease

Snippet

Sponsor: University of Regensburg | Conditions: End Stage Liver Disease, Impaired Renal Function | Phase 3 | Status: COMPLETED